Golimumab


( Last Updated : July 12, 2013)
Generic Name:
Golimumab
Project Status:
Complete
Therapeutic Area:
Ulcerative colitis
Manufacturer:
Janssen Inc.
Call for patient/clinician input open:
Brand Name:
Simponi
Project Line:
Reimbursement Review
Project Number:
SR0341-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC

Details


Submission Type:
Initial
Indications:
Ulcerative colitis
Recommendation Type:
Do not list at the submitted price
Final Recommendation: